In this study, by reviewing the data in the Kaplan Meier plotter and bc-GenExMiner 4.0, we observed that high MMP1 expression is associated with significantly worse survival outcomes no matter in all breast cancer patients or only in ER+ breast cancer patients. This evidence concerns the gene MMP1 and breast carcinoma.